Your browser doesn't support javascript.
loading
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
Bonaca, Marc P; Storey, Robert F; Theroux, Pierre; Steg, P Gabriel; Bhatt, Deepak L; Cohen, Marc C; Im, KyungAh; Murphy, Sabina A; Magnani, Giulia; Ophuis, Ton Oude; Rudah, Mikhail; Parkhomenko, Alexander; Isaza, Daniel; Kamensky, Gabriel; Goudev, Assen; Montalescot, Gilles; Jensen, Eva C; Johanson, Per; Braunwald, Eugene; Sabatine, Marc S.
Afiliação
  • Bonaca MP; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. Electronic address: mbonaca@partners.org.
  • Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.
  • Theroux P; University of Montreal, Montreal, Quebec, Canada.
  • Steg PG; Département de Cardiologie Hôpital Bichat, Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Bhatt DL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Cohen MC; Newark Beth Israel Medical Center, Rutgers Medical School, Newark, New Jersey.
  • Im K; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Magnani G; University Hospital Zurich, Zurich, Switzerland.
  • Ophuis TO; CWZ Hospital, Nijmegen, the Netherlands.
  • Rudah M; Cardiology Research Center, Moscow, Russian Federation.
  • Parkhomenko A; Institute of Cardiology, Kiev, Ukraine.
  • Isaza D; Fundación Cardioinfantil, Bogotá, Colombia.
  • Kamensky G; Department of Noninvasive Cardiovascular Diagnostics, Vth Internal Clinic, University Hospital Bratislava, Bratislava, Slovakia.
  • Goudev A; Medical University of Sofia, Queen Ioanna University Hospital, Sofia, Bulgaria.
  • Montalescot G; Sorbonne Université Paris 6, ACTION Study Group, INSERM-UMRS 1166, Institut de Cardiologie, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
  • Jensen EC; AstraZeneca, Mölndal, Sweden.
  • Johanson P; AstraZeneca, Mölndal, Sweden.
  • Braunwald E; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
  • Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
J Am Coll Cardiol ; 70(11): 1368-1375, 2017 Sep 12.
Article em En | MEDLINE | ID: mdl-28882235
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Terapia Trombolítica / Adenosina / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Terapia Trombolítica / Adenosina / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2017 Tipo de documento: Article